December 14, 2000
Triaminic Cold Remedies Containing Phenylpropanolamine Withdrawn
from the Market
Summit, NJ (SafetyAlerts) - Novartis Consumer
Health Inc. has voluntarily withdrawn certain Triaminic cold remedies because they contain
the decongestant, phenylpropanolamine. Novartis has stated that this is not a
mandatory recall, but a voluntary action to withdraw the products and replace them with
Last November, the Food and Drug Administration
issued a nationwide warning against using over-the-counter drugs containing
The FDA stated that a recent study reported that
taking phenylpropanolamine increases the risk of hemorrhagic stroke (bleeding into the
brain or into tissue surrounding the brain) in women. Men may also be at risk. Although
the risk of hemorrhagic stroke is very low, FDA recommends that consumers not use any
products that contain phenylpropanolamine. Click here to
view the FDA warning.
The Triaminic cold remedies that have been with drawn are:
Cold & Allergy
Cold & Cough
Expectorant Chest Congestion.
Novartis Consumer Health has stated that they have
since reformulated these products with the decongestant pseudoephedrine. Products
containing pseudoephedrine are not affected by the withdraw.
Consumers who have purchased one of the above
Triaminic products containing phenylpropanolamine should call Novartis Consumer Health at
1-800-548-3708 with the lot numbers on the box for a refund.
Notice of this product warning was sent via email
to SafetyAlerts subscribers December
14, 2000. For more information regarding the SafetyAlerts free email alert service
please click here.
Safety Alerts compiles comprehensive safety recall information for
the United States. SafetyAlerts Newsletter is a free
email service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.